Business / Finance

RSS

Tikcro enters into research and license agreement with Yeda

Tikcro Technologies Ltd. today announced that it has entered into a research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science in Israel.

30 Dec 2014

Abbott reports tender offer results to purchase 5.125% Senior Notes issued by CFR International SpA

Abbott today reported early results for the tender offer and related consent solicitation commenced by its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation to purchase for cash any or all of the outstanding 5.125% Senior Notes due 2022 (the "Notes") issued by CFR International SpA, a Chilean corporation and subsidiary of ALH.

30 Dec 2014

Gannett Healthcare Group sold to OnCourse Learning

Gannett Co., Inc. today announced it has sold Gannett Healthcare Group to OnCourse Learning, an online education and training provider.

30 Dec 2014

MagnaChip launches new bio-sensor research collaboration

MagnaChip Semiconductor Corporation, a Korea-based designer and manufacturer of analog and mixed-signal semiconductor products, today announced it has launched a research collaboration focused on developing innovative, cost-effective silicon magnetic bio-sensor technology capable of monitoring extremely rare cells in blood.

30 Dec 2014

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.

29 Dec 2014

Tianyin Pharmaceutical releases unaudited preliminary financial results for Q1 FY 2015

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.

25 Dec 2014

Vermillion closes previously announced private placement with investors

Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, announced today that the Company closed its previously announced private placement with investors including Oracle Investment Management, Jack W. Schuler, Birchview Fund LLC and several Vermillion directors. Total proceeds were $10.5 million, before offering expenses.

25 Dec 2014

Soligenix closes previously announced registered public offering

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that on December 24, 2014 it closed its previously announced registered public offering.

25 Dec 2014

PlasmaTech Biopharmaceuticals closes underwritten public offering of common stock

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase up to an aggregate 3,500,000 shares of common stock, at an offering price of $4.00 per share and $.01 per warrant.

25 Dec 2014

IMRIS closes private placement offering of 10,563,380 units

IMRIS Inc. today announced it has closed the private placement offering of 10,563,380 units at an offering price of US$0.284 per unit.

25 Dec 2014

CCG completes $8M in Tax Credits to expand, consolidate healthcare services in Sharon

Commonwealth Cornerstone Group (CCG) today announced the completion of an $8 million New Markets Tax Credits transaction on Tuesday to help fund the expansion and consolidation of healthcare services provided by Primary Health Network (PHN) in Sharon.

25 Dec 2014

Comprehensive analysis of the global composites in orthopedic market

Composites in global orthopedic industry are expected to grow at an average rate of 8.1%. The US has highest consumption in terms of value and volume. Hip, knee and spine surgeries are the common orthopedic procedures in the developed world while in emerging economies they have a lower penetration.

24 Dec 2014

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, announced today the first signed Middle East sales/distribution agreement for lead product Neutrolin with distributor Arabian Trade House in the Kingdom of Saudi Arabia.

23 Dec 2014

Shandong Taibang Biological Products earns GMP certification for new production facility

China Biologic Products, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., has received Good Manufacturing Practices ("GMP") certification from the China Food and Drug Administration (the "CFDA") for its new coagulation factor production facility.

23 Dec 2014

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".

23 Dec 2014

Origins Behavioral Healthcare agrees to acquire two addiction treatment centers from Caron

A major deal in the substance abuse recovery industry will mean new treatment options for people struggling with addiction. Origins Behavioral Healthcare and Caron Treatment Centers announced today an agreement in which Origins will acquire two addiction treatment centers owned and operated by Caron: Hanley Center in West Palm Beach and Gate Lodge in Vero Beach, Fla.

21 Dec 2014

Roche announces acquisition of Bina Technologies

Roche announced today the acquisition of Bina Technologies, Inc., a privately held company based in Redwood City, California, USA. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data.

19 Dec 2014

Lilly, Adocia team up to develop BioChaperone Lispro insulin for treatment of diabetes

Eli Lilly and Company and Adocia today announced a worldwide licensing collaboration focused on developing an ultra-rapid insulin, known as BioChaperone Lispro, for treatment in people with type 1 and type 2 diabetes.

19 Dec 2014

Aviv REIT acquires 28 properties for $305 million from Diamond Senior Living

Aviv REIT, Inc. announced today that it acquired 28 properties (plus an office building) for $305 million from Diamond Senior Living, LLC, a subsidiary of General Electric Credit Corporation of Tennessee (itself a subsidiary of General Electric Capital Corporation).

18 Dec 2014

Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the companies have entered into a strategic collaboration for the further clinical development and commercialization of CMX157.

18 Dec 2014

Business / Finance

Tikcro enters into research and license agreement with Yeda

Abbott reports tender offer results to purchase 5.125% Senior Notes issued by CFR International SpA

Gannett Healthcare Group sold to OnCourse Learning

MagnaChip launches new bio-sensor research collaboration

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Tianyin Pharmaceutical releases unaudited preliminary financial results for Q1 FY 2015

Vermillion closes previously announced private placement with investors

Soligenix closes previously announced registered public offering

PlasmaTech Biopharmaceuticals closes underwritten public offering of common stock

IMRIS closes private placement offering of 10,563,380 units

CCG completes $8M in Tax Credits to expand, consolidate healthcare services in Sharon

Comprehensive analysis of the global composites in orthopedic market

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

Shandong Taibang Biological Products earns GMP certification for new production facility

CytoSorbents starts trading on The Nasdaq Capital Market

Origins Behavioral Healthcare agrees to acquire two addiction treatment centers from Caron

Roche announces acquisition of Bina Technologies

Lilly, Adocia team up to develop BioChaperone Lispro insulin for treatment of diabetes

Aviv REIT acquires 28 properties for $305 million from Diamond Senior Living

Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News